. "Zhang, J. X." . . . . . "Pechar, Michal" . . "R\u016Fzn\u00E1 mno\u017Estv\u00ED jednoho ze t\u0159\u00ED typ\u016F \u0161t\u011Bpiteln\u00FDch methoxypolyethylenglykol\u016F (mPEG)-fosfolipidu nebo jeho ne\u0161t\u011Bpiteln\u00E9ho analoga (mPEG-DSPE) byla zabudov\u00E1na do pH-sensitivn\u00EDch liposom\u016F s dioleoylfosfatidylethanolaminem a cholesterylhemisukcin\u00E1tem v pom\u011Bru 6:4 Byl studov\u00E1n vliv mno\u017Estv\u00ED mPEG-fosfolipidu na eliminaci liposomu z krevn\u00ED plasmy a na rychlost uvol\u0148ov\u00E1ni jejich obsah\u016F."@cs . "Various amounts of one of three different types of cleavable methoxy polyethylene glycol (mPEG)-phospholipids or of a non-cleavable counterpart (mPEG-DSPE) were included into pH-sensitive liposome formulations containing dioleoylphosphatidylethanolamine and cholesterylhemisuccinate at a 6:4 molar ratio, and the effect on plasma clearance and contents release rates was determined."@en . "Pharmacological Research" . "RIV/61389013:_____/04:00105813" . "Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers" . "RIV/61389013:_____/04:00105813!RIV/2005/AV0/A55005/N" . "[5F6C64517DFA]" . "P(KSK4050111), Z(AV0Z4050913)" . "49" . "Mullah, N." . . . "185;198" . "5"^^ . . . "Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers"@en . "Zalipsky, S." . "2" . . . "1043-6618" . "1"^^ . "Farmakologick\u00E9 vlastnosti liposom\u016F na b\u00E1zi dioleoylfosfatidylethanolamine/cholesterylhemisukcin\u00E1t\u016F s r\u016Fzn\u00FDmi typy \u0161t\u011Bpiteln\u00FDch lipopolymer\u016F"@cs . "579303" . "Farmakologick\u00E9 vlastnosti liposom\u016F na b\u00E1zi dioleoylfosfatidylethanolamine/cholesterylhemisukcin\u00E1t\u016F s r\u016Fzn\u00FDmi typy \u0161t\u011Bpiteln\u00FDch lipopolymer\u016F"@cs . "14"^^ . "Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers"@en . . "pH-sensitive liposomes;polyethyleneglycol;pharmacokinetics"@en . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . . "Various amounts of one of three different types of cleavable methoxy polyethylene glycol (mPEG)-phospholipids or of a non-cleavable counterpart (mPEG-DSPE) were included into pH-sensitive liposome formulations containing dioleoylphosphatidylethanolamine and cholesterylhemisuccinate at a 6:4 molar ratio, and the effect on plasma clearance and contents release rates was determined." . "Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers" . "Allen, T. M." .